Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora Cocco

Showing results (81-90 of 267) with videos related to

Pageof 27
Sort By:
Annals of Clinical and Translational Neurology|October 20, 2020
Walking in multiple sclerosis improves with tDCS: a randomized, double-blind, sham-controlled studyGiuseppina Pilloni, Claire Choi, Michael T Shaw, et al.
Frontiers in Neurology|September 20, 2021
The Dimethyl Fumarate Experience: A Handy Drug With Broad Clinical UtilityLorena Lorefice, Elisa Casaglia, Marzia Fronza, et al.
Frontiers in Neurology|March 20, 2026
Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosisPietro Annovazzi, Marinella Clerico, Eleonora Cocco, et al.
Journal of Proteomics|August 8, 2018
Top-down proteomic profiling of human saliva in multiple sclerosis patientsBarbara Manconi, Barbara Liori, Tiziana Cabras, et al.
Metabolites|March 29, 2023
Metabolomic Changes in Patients Affected by Multiple Sclerosis and Treated with FingolimodFederica Murgia, Lorena Lorefice, Antonio Noto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2014
Human interferon regulatory factor 5 homologous epitopes of Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis induce a specific humoral and cellular immune response in multiple sclerosis patientsDavide Cossu, Giuseppe Mameli, Grazia Galleri, et al.
Journal of Molecular Neuroscience : MN|July 3, 2016
Soluble BAFF Level Is Not Correlated to Mycobacterium avium Subspecies Paratuberculosis Antibodies and Increases After Interferon-β Therapy in Multiple Sclerosis PatientsGiuseppe Mameli, Davide Cossu, Elisa Caggiu, et al.
Multiple Sclerosis and Related Disorders|February 8, 2026
Reduced retinal neuronal injury as a consequence of high efficacy DMT treatment: an OCT studyAntonio Francesco Vacca, Su-Chun Huang, Elisa Idini, et al.
Neurology|December 8, 2017
PML in a person with multiple sclerosis: Is teriflunomide the felon?Lorena Lorefice, Giuseppe Fenu, Simonetta Gerevini, et al.
Journal of Neuroimmunology|April 19, 2002
Chromosome 7q21-22 and multiple sclerosis: evidence for a genetic susceptibility effect in vicinity to the protachykinin-1 geneKoen Vandenbroeck, Pierre Fiten, Shirley Heggarty, et al.
Pageof 27

Showing results (81-90 of 267) with videos related to

Sort By:
Pageof 27
Annals of Clinical and Translational Neurology|October 20, 2020
Walking in multiple sclerosis improves with tDCS: a randomized, double-blind, sham-controlled studyGiuseppina Pilloni, Claire Choi, Michael T Shaw, et al.
Frontiers in Neurology|September 20, 2021
The Dimethyl Fumarate Experience: A Handy Drug With Broad Clinical UtilityLorena Lorefice, Elisa Casaglia, Marzia Fronza, et al.
Frontiers in Neurology|March 20, 2026
Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosisPietro Annovazzi, Marinella Clerico, Eleonora Cocco, et al.
Journal of Proteomics|August 8, 2018
Top-down proteomic profiling of human saliva in multiple sclerosis patientsBarbara Manconi, Barbara Liori, Tiziana Cabras, et al.
Metabolites|March 29, 2023
Metabolomic Changes in Patients Affected by Multiple Sclerosis and Treated with FingolimodFederica Murgia, Lorena Lorefice, Antonio Noto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2014
Human interferon regulatory factor 5 homologous epitopes of Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis induce a specific humoral and cellular immune response in multiple sclerosis patientsDavide Cossu, Giuseppe Mameli, Grazia Galleri, et al.
Journal of Molecular Neuroscience : MN|July 3, 2016
Soluble BAFF Level Is Not Correlated to Mycobacterium avium Subspecies Paratuberculosis Antibodies and Increases After Interferon-β Therapy in Multiple Sclerosis PatientsGiuseppe Mameli, Davide Cossu, Elisa Caggiu, et al.
Multiple Sclerosis and Related Disorders|February 8, 2026
Reduced retinal neuronal injury as a consequence of high efficacy DMT treatment: an OCT studyAntonio Francesco Vacca, Su-Chun Huang, Elisa Idini, et al.
Neurology|December 8, 2017
PML in a person with multiple sclerosis: Is teriflunomide the felon?Lorena Lorefice, Giuseppe Fenu, Simonetta Gerevini, et al.
Journal of Neuroimmunology|April 19, 2002
Chromosome 7q21-22 and multiple sclerosis: evidence for a genetic susceptibility effect in vicinity to the protachykinin-1 geneKoen Vandenbroeck, Pierre Fiten, Shirley Heggarty, et al.
Pageof 27